The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma

Breast Care (Basel). 2008;3(s2):20-24. doi: 10.1159/000151736. Epub 2008 Oct 16.
No abstract available